Concepedia

Bailin Shaw

BS

8

Publications

1.3K

Citations

8

H-Index

2009

Active since

Affiliations

AbbVie (United States)(Current)

Structural Genomics Consortium

University of Toronto

Bailin Shaw is an author at AbbVie (United States) specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

2009–2021

8

Publications

8

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren Lasko, Clarissa G. Jakob, Rohinton Edalji et al. · Nature · 2017 · 813 citations · Full text

, , +8

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Yupeng He, Sujatha Selvaraju, Michael L. Curtin et al. · Nature Chemical Biology · 2017 · 229 citations · Full text

, , +7

Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2

Ramzi F. Sweis, Zhi Wang, Mikkel A. Algire et al. · ACS Medicinal Chemistry Letters · 2015 · 65 citations · Full text

, , +17

Characterization of the active site of S. aureus monofunctional glycosyltransferase (Mtg) by site-directed mutation and structural analysis of the protein complexed with moenomycin

H. Heaslet, Bailin Shaw, Anil Mistry et al. · Journal of Structural Biology · 2009 · 57 citations

, , +8

Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315

Clarissa G. Jakob, Anup K. Upadhyay, Pamela L. Donner et al. · Journal of Medicinal Chemistry · 2018 · 55 citations · Full text

, , +17

Rows per page

1–5 of 8